You are here

weight loss

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Flag link:

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Fast Company

Flag link:

Novo Nordisk Is Already Working on Ozempic 2.0

Novo Nordisk Is Already Working on Ozempic 2.0

Motley Fool

Flag link:

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

FT.com

Flag link:

Are weight loss drugs a win for the global economy?

Are weight loss drugs a win for the global economy?

Pharma Voice

Flag link:

Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says

Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says

Fierce Pharma

Flag link:

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Forbes

Lars Fruergaard Jorgensen

Flag link:

3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer

3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer

Motley Fool

cardiovascular disease

Flag link:

Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print

Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print

Forbes

Flag link:

Demand for weight loss drugs soars to nearly half of Americans

Demand for weight loss drugs soars to nearly half of Americans

Pharma Voice

Flag link:

Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance

Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance

MedCity News

Flag link:

Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?

Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?

Motley Fool

Flag link:

Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval

Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval

Fierce Pharma

Flag link:

New weight loss drugs carry high price tags and lots of questions for seniors

New weight loss drugs carry high price tags and lots of questions for seniors

Medical Marketing and Media

Flag link:

Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher

Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher

Motley Fool

Flag link:

More payers could stanch off-label use of Ozempic

More payers could stanch off-label use of Ozempic

Medical Marketing and Media

Flag link:

Could Pfizer Have an Ozempic Killer on the Way?

Could Pfizer Have an Ozempic Killer on the Way?

Motley Fool

Flag link:

Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence

Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence

Biopharma Reporter

Flag link:

This Could Be Novo Nordisk's Next Big Weight-Loss Product

This Could Be Novo Nordisk's Next Big Weight-Loss Product

Motley Fool

Flag link:

Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

Investors Business Daily

clinical trials

Flag link:

Pages